Literature DB >> 31243083

Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21".

Amritha Ramakrishnan1, Nina M Schumack2,3, Christina L Gariepy2,3, Heather Eggleston2,3, Gladys Nunez1, Nereyda Espinoza1, Monica Nieto1, Rosa Castillo1, Jesus Rojas1, Andrea J McCoy1, Zoltan Beck4, Gary R Matyas5, Carl R Alving5, Patricia Guerry3, Frédéric Poly3, Renee M Laird6,3.   

Abstract

Entities:  

Year:  2019        PMID: 31243083      PMCID: PMC6595154          DOI: 10.1128/mSphere.00440-19

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


× No keyword cloud information.

ERRATUM

Volume 4, issue 3, e00101-19, 2019, https://doi.org/10.1128/mSphere.00101-19. In Table 1, the third value in the CPS-CRM + ALFQ row should be 86, not 8. The corrected table appears here.
TABLE 1

Protective efficacy of the CPS-CRM vaccine in A. nancymaae NHPs using various adjuvants

GroupNo. ofanimalsDiarrhea attackrate, n (%)Protective efficacyagainst diarrhea (%)a Pb
CPS-CRM + alum105 (50)290.43
CPS-CRM + ALF174 (24)660.008
CPS-CRM + ALFQ101 (10)860.005
PBS2014 (70)

Protective efficacy was calculated as follows: [(attack rate of PBS-treated animals − attack rate of vaccinated animals)/attack rate of PBS-treated animals] × 100.

Determined using a Fisher exact test with no adjustment for multiple comparisons.

Protective efficacy of the CPS-CRM vaccine in A. nancymaae NHPs using various adjuvants Protective efficacy was calculated as follows: [(attack rate of PBS-treated animals − attack rate of vaccinated animals)/attack rate of PBS-treated animals] × 100. Determined using a Fisher exact test with no adjustment for multiple comparisons.
  1 in total

Review 1.  Army Liposome Formulation (ALF) family of vaccine adjuvants.

Authors:  Carl R Alving; Kristina K Peachman; Gary R Matyas; Mangala Rao; Zoltan Beck
Journal:  Expert Rev Vaccines       Date:  2020-03-31       Impact factor: 5.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.